Private Equity 3 Days

Last updated: May 17, 2026, 11:30 AM ET

Deal Activity & Fundraising

Closed merger combined the Charlesbank‑backed orthopedics specialist Tecomet with Nordic‑backed Orchid Orthopedic Solutions, creating a unified entity that will operate under the Tecomet name and expand its product portfolio across Europe and North America. In parallel, completed take‑private of Enhabit Home Health & Hospice by Kinderhook raised capital to support the provider’s growth in the senior‑care market, with former Enhabit president Barb Jacobsmeyer retaining operational leadership. Meanwhile, launched fund saw General Atlantic commit capital to Power GEM, a battery‑technology firm, underscoring the firm’s push into clean‑energy hardware after TA Associates’ earlier backing. These transactions illustrate private‑equity sponsors’ focus on consolidating fragmented healthcare and energy segments to achieve scale and cross‑sell opportunities.

Strategic Exits & Portfolio Realignments

Exited China fund disclosed that Schroders will transfer its wholly‑owned China fund management business to Neuberger Berman, a move that reflects growing pressure on foreign managers to partner with firms possessing deeper local distribution networks. At the same time, considering bid for Magnum Ice Cream, valued below its 2022 IPO price, attracted interest from Blackstone and CD&R, who view the undervalued consumer brand as a platform for margin‑driven roll‑ups in the frozen‑dessert sector. The potential acquisition highlights how private‑equity players are hunting for distressed public listings that can be taken private at attractive multiples.

Debt‑Heavy Restructurings

Engineered debt cut reported that a consortium led by Blackstone and KKR will restructure Affordable Care Services, writing off roughly 70% of its $1.2bn debt load and converting the remainder into equity. The deal, financed largely by direct lenders, aims to stabilize the provider’s cash flow and fund a turnaround of its home‑health operations. A similar pattern emerged in Europe, where co‑invested logistics stake saw CPP Investments pledge €400 m alongside Blackstone into French last‑mile logistics platform Proudreed, targeting a market poised for e‑commerce‑driven expansion. Both transactions demonstrate how sponsors are leveraging distressed‑debt opportunities to gain controlling stakes in essential service providers.

Sector‑Specific Plays

Targeted testing deals outlined five recent private‑equity investments in the testing, inspection, certification and compliance (TICC) space, including Ardian, Blackstone, Bridgepoint and EQT, drawn by the sector’s recurring‑revenue models and regulatory tailwinds. In the life‑science arena, invested in data analytics highlighted Eir Partners’ backing of Quartz Bio, a platform that aggregates clinical‑trial data to accelerate drug‑R&D, reflecting investors’ belief that data‑centric solutions will mitigate the rising cost of pharmaceutical development. These focused bets indicate that sponsors are allocating capital to niche verticals where technology and regulation combine to create defensible cash flows.

Emerging Market & ESG Considerations

Won discrimination ruling saw Mercury Capital successfully defend against a lawsuit alleging racial bias, a verdict that may influence how LPs evaluate ESG and governance practices within private‑equity firms. Finally, backed family‑care platform announced L Catterton’s minority stake in Saint Bella Group, a Chinese‑origin family‑care operator, signaling continued appetite for cross‑border consumer investments despite heightened geopolitical scrutiny. Together, these developments underscore the sector’s balancing act between rigorous governance, strategic growth, and the pursuit of high‑margin niche markets.